Allianz Asset Management’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-399,591
Closed -$11.7M 2814
2017
Q3
$11.7M Buy
399,591
+388,000
+3,347% +$10.9M 0.01% 1252
2017
Q2
$305K Hold
11,591
﹤0.01% 2511
2017
Q1
$271K Sell
11,591
-1,972
-15% -$48.7K ﹤0.01% 2501
2016
Q4
$341K Sell
13,563
-32,113
-70% -$811K ﹤0.01% 2439
2016
Q3
$1.27M Sell
45,676
-27,561
-38% -$706K ﹤0.01% 2148
2016
Q2
$1.81M Sell
73,237
-106,110
-59% -$2.63M ﹤0.01% 1963
2016
Q1
$3.96M Sell
179,347
-3,325
-2% -$88.5K ﹤0.01% 1538
2015
Q4
$6.39M Sell
182,672
-714
-0.4% -$22.4K 0.01% 1253
2015
Q3
$5.22M Sell
183,386
-176,041
-49% -$5.91M 0.01% 1266
2015
Q2
$12M Sell
359,427
-24,606
-6% -$755K 0.01% 1021
2015
Q1
$10.8M Sell
384,033
-4,922
-1% -$122K 0.01% 924
2014
Q4
$8.05M Buy
388,955
+92,608
+31% +$2.2M 0.01% 1042
2014
Q3
$7.24M Buy
296,347
+44,334
+18% +$1.18M 0.01% 951
2014
Q2
$7.21M Buy
252,013
+4,290
+2% +$119K 0.01% 837
2014
Q1
$6.93M Sell
247,723
-11,105
-4% -$273K 0.01% 859
2013
Q4
$5.57M Buy
258,828
+8,891
+4% +$162K 0.01% 915
2013
Q3
$3.32M Sell
249,937
-66,228
-21% -$892K ﹤0.01% 1047
2013
Q2
$4.38M Buy
+316,165
New +$4.48M 0.01% 933

Allianz Asset Management's PMC Position: Q4 2017 in Review

Allianz Asset Management sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 399,591 shares — an estimated $11.7M sold.

Allianz Asset Management first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $12M in Q2 2015. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

  • Allianz Asset Management reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
  • Allianz Asset Management sold 399,591 PharMerica Corporation shares in Q4 2017, an estimated $11.7M.
  • Allianz Asset Management first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
  • Allianz Asset Management's PharMerica Corporation position peaked at $12M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on Allianz Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.